CASI icon

CASI Pharmaceuticals
CASI

Overview Fund Activity

29 hedge funds and large institutions have $2.41M invested in CASI Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 2 closing their positions.

Holders
29
Holders Change
+3
Holders Change %
+11.54%
% of All Funds
0.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
6
Reduced
8
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$22K
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$19K
3
BlackRock
3
BlackRock
New York
$309K
4
UBS Group
4
UBS Group
Switzerland
$8K
5
Creative Planning
5
Creative Planning
Kansas
$2K

Top Sellers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$302K
2
VKH
2
Virtu KCG Holdings
New York
$0
3
Renaissance Technologies
3
Renaissance Technologies
New York
$112K
4
WSCM
4
Wellington Shields Capital Management
New York
$762K
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$40K
Name Market Value Shares Shares
Change 		Shares
Change %
IA
26
IFP Advisors
Florida
$0 3 – –
FWM
27
Focused Wealth Management
New York
$0 45 – –
RFM
28
Royal Fund Management
Florida
$0 9 – –
NFG
29
Next Financial Group
Texas
$0 2 +2 New
JPMorgan Chase & Co
30
JPMorgan Chase & Co
New York
$0 9 +9 New
SPIA
31
Steward Partners Investment Advisory
New York
$0 45 +45 New
1
2